Pacifica Partners’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43K | Hold |
30
| – | – | ﹤0.01% | 489 |
|
|
2025
Q1 | $979 | Hold |
30
| – | – | ﹤0.01% | 483 |
|
|
2024
Q4 | $1.24K | Hold |
30
| – | – | ﹤0.01% | 448 |
|
|
2024
Q3 | $1.41K | Hold |
30
| – | – | ﹤0.01% | 467 |
|
|
2024
Q2 | $1.62K | Hold |
30
| – | – | ﹤0.01% | 483 |
|
|
2024
Q1 | $2.13K | Hold |
30
| – | – | ﹤0.01% | 459 |
|
|
2023
Q4 | $2.12K | Hold |
30
| – | – | ﹤0.01% | 485 |
|
|
2023
Q3 | $1.29K | Hold |
30
| – | – | ﹤0.01% | 491 |
|
|
2023
Q2 | $1.7K | Hold |
30
| – | – | ﹤0.01% | 435 |
|
|
2023
Q1 | $1.36K | Hold |
30
| – | – | ﹤0.01% | 454 |
|
|
2022
Q4 | $1.23K | Hold |
30
| – | – | ﹤0.01% | 437 |
|
|
2022
Q3 | $2K | Hold |
30
| – | – | ﹤0.01% | 422 |
|
|
2022
Q2 | $2K | Hold |
30
| – | – | ﹤0.01% | 437 |
|
|
2022
Q1 | $2K | Hold |
30
| – | – | ﹤0.01% | 433 |
|
|
2021
Q4 | $2K | Hold |
30
| – | – | ﹤0.01% | 430 |
|
|
2021
Q3 | $3K | Hold |
30
| – | – | ﹤0.01% | 400 |
|
|
2021
Q2 | $5K | Buy |
+30
| New | +$5K | ﹤0.01% | 351 |
|
|
2020
Q2 | – | Sell |
-50
| Closed | -$2K | – | 379 |
|
|
2020
Q1 | $2K | Hold |
50
| – | – | ﹤0.01% | 322 |
|
|
2019
Q4 | $3K | Buy |
+50
| New | +$3K | ﹤0.01% | 307 |
|